News
WHO declares aspartame as possible carcinogen
- Author:
- Sharon Worcester, MA
“In short the evidence that aspartame causes primary liver cancer, or any other cancer in humans, is very weak.”
News
Higher alcohol consumption linked to early-onset CRC
- Author:
- Sharon Worcester, MA
Compared with light drinking, moderate and heavy drinking were associated with a significantly elevated risk of early-onset CRC.
News
FDA approves talazoparib for metastatic prostate cancer
- Author:
- Sharon Worcester, MA
The new approval is based on findings from the randomized, placebo-controlled, phase 3 TALAPRO-2 trial.
News
Widespread carboplatin, cisplatin shortages: NCCN survey
- Author:
- Sharon Worcester, MA
Only 64% of centers said they are still able to continue treating all current patients receiving carboplatin.
News
FDA approves new indication for avapritinib
- Author:
- Sharon Worcester, MA
Purported “first and only approved medicine” to treat adults with indolent systemic mastocytosis has been greenlit by the FDA.
News
Focus of new ASH VTE guidelines: Thrombophilia testing
- Author:
- Sharon Worcester, MA
New guidelines recommend testing for thrombophilia in patients with VTE provoked by a nonsurgical major transient risk factor or associated with...
News
SCC from breast implants: Negligible risk, study finds
- Author:
- Sharon Worcester, MA
Regarding SCC, “whether the observed elevated risk is associated with the implants is difficult to interpret because it is based on only one case...
News
Phase 3 trial: Maribavir yields post-transplant benefits
- Author:
- Sharon Worcester, MA
Study findings “provide supportive evidence of the potential for long-term benefit” with maribavir for the treatment of post-transplant CMV.
News
Novel fluorescence guidance improves lumpectomy outcomes
- Author:
- Sharon Worcester, MA
Pegulicianine (Lumisight), an investigational and activatable fluorescent imaging agent used with a novel direct visualization system, helped...
News
Motixafortide may improve MM outcomes
- Author:
- Sharon Worcester, MA
A new drug approval for motixafortide is currently under review by the Food and Drug Administration.
News
FDA approves new Merkel cell carcinoma treatment
- Author:
- Sharon Worcester, MA
This marks the first regulatory approval for retifanlimab-dlwr, a PD-1 inhibitor.
News
Depression tied to inflammation and survival in lung cancer
- Author:
- Sharon Worcester, MA
A new study’s findings underscore the importance of assessing and treating depression in patients with cancer, particularly given the high rate of...
News
Venetoclax shows promise for r/r hairy cell leukemia
- Author:
- Sharon Worcester, MA
Italian study suggests benefits of administering venetoclax for patients with r/r cases of hairy cell leukemia, a rare blood cancer,
News
FDA strengthens mammography regulations: Final rule
- Author:
- Sharon Worcester, MA
A final rule requires that mammography facilities notify patients about the density of their breasts.
News
Phase 3 results: Ponatinib bests imatinib for Ph+ALL
- Author:
- Sharon Worcester, MA
First prospective study of third-generation TKI ponatinib showed its comparative benefit for the most common subtype of adult ALL.